The new prosthetic group 18 F-TEG-DBCO (dibenzocyclooctyne) can be prepared within a total reaction time of 60 min including purification with an overall yield (n.d.c.) of 34 ± 5%. Copper-free click cycloadditions with an azido-cRGD, a folate-azide and two α-MSH analogue azido-peptides resulted in very high RCYs and fast reaction kinetics.
The new prosthetic group 18 F-TEG-DBCO (dibenzocyclooctyne) can be prepared within a total reaction time of 60 min including purification with an overall yield (n.d.c.) of 34 ± 5%. Copper-free click cycloadditions with an azido-cRGD, a folate-azide and two α-MSH analogue azido-peptides resulted in very high
RCYs and fast reaction kinetics.
For non-invasive in vivo imaging of processes and pharmacokinetics of radiolabeled biomolecules, the positron emission tomography (PET) is one of the most powerful methods. 1 For PET applications, fluorine-18 has ideal nuclear characteristics and is the most commonly applied radionuclide in PET. The relatively long half-life of 110 minutes enables multi-step radiosyntheses, and the rather low β + -energy ensures a very high spatial resolution in tomography. 2 The challenge for nuclear chemists consists in finding appropriate 18 F-labeling strategies, especially for sensitive biomolecules. Most of them are sensitive to the commonly used harsh conditions in direct 18 F-labeling reactions such as high temperatures and strong basic conditions. 3, 4 As a result, the development of indirect labeling strategies via 18 F-prosthetic groups, which can subsequently be attached to biomolecules under mild reaction conditions, is needed. [5] [6] [7] Besides, the radiolabeling reaction should allow bioorthogonal 18 F-labeling to treat the multitude of functional groups in bioactive compounds with respect. The most prominent example of such reactions, which fulfills all the mentioned criteria, is the copperĲI)-catalyzed azide-alkyne cycloaddition (CuAAC) first published by Sharpless et al. in 2001. 8 This variant of the Huisgen 1,3-dipolar cycloaddition of terminal alkynes and azides enables 18 F-labeling with high specificity and excellent yields under mild conditions. 9, 10 In the past decade, a widespread spectrum of PET tracers has been synthesized using the CuAAC method for 18 F-labeling of bioactive compounds. 11 One of the latest developments is based on an amino acid, which is thought to minimize the influence on the pharmacokinetic properties of the intended radiotracer. As an amino acid derived 18 F-prosthetic group, it is particularly suitable for peptides and proteins. 12 However, with all the advantages of the copperĲI)-catalyzed cycloaddition, there is one major disadvantage. The need for cytotoxic copper species as a catalyst in the click reaction causes an extensive work-up guaranteeing the complete removal of copper for in vivo applications. This fact led to the necessity of alternative fast and copper-free click reaction strategies. By using strained alkynes instead of terminal alkynes, copper is no longer needed to catalyze the click reaction. These so-called strain-promoted click reactions were first reported by Baskin et al. 13 F-labeling of peptides via a strainpromoted click reaction without the use of a copper species, showing the high potential of this concept for 18 F-labeling of biomolecules. 15 Our aim was to develop a new 18 F-prosthetic group based on (aza)dibenzocyclooctyne (DBCO) for radiolabeling of biomolecules such as peptides and microproteins. For reduced lipophilicity, we introduced a triethylene glycol spacer to the (aza)dibenzocyclooctyne. Two different leaving groups, different bases, base concentrations and precursor amounts during radiolabeling were evaluated for optimized 18 F-labeling. Consequently, two DBCO-based precursors and the non-radioactive reference compound were synthesized, and the 18 F-labeling reaction was optimized. Finally, we performed a proof-of-principle click reaction with the new 18 F-labeled prosthetic group and an azidofunctionalized cyclic Arg-Gly-Asp (cRGD) peptide as a model system. This peptide is used as the gold-standard vector in targeting the α V β 3 integrin. 16, 17 Furthermore, we carried out further copper-free click reactions using a folate-azide for targeting the folate receptor and two α-MSH analogue azido-functionalized peptides with high specificities to the melanocortin receptor 1 (MC1R). The syntheses of reference compound 11 and the 18 F-labeling precursors 9 and 10 are depicted in Scheme 1. The synthesis started from commercially available triethylene glycol 2. In the first step, 2 was reacted with tert-butylacrylate 1 to create a carboxylic acid function enabling the desired amide coupling. 18 Compound 3 was then reacted with either p-toluenesulfonyl chloride 19 or methanesulfonyl chloride 20 to transfer the hydroxyl function into suitable leaving groups for the nucleophilic radiofluorination reaction. Subsequently, protected intermediates 4 and 6 were deprotected by trifluoroacetic acid in dichloromethane at room temperature to yield 5 and 7. 21 Both linker groups were coupled via an amide bond to the dibenzocyclooctyne (DBCO)-amine 8, using HBTU N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)-uranium-hexafluorophosphate (HBTU) as coupling reagent and N,N-diisopropylethylamine (DIPEA) as base. The coupling was performed at room temperature for 12 h to yield the desired precursors for the 18 F-fluorination reaction in overall yields of 28% (for precursor 9) and 56% (for precursor 10) over four steps. Due to the quite high costs for DBCO-amine 8, we aimed to insert this component in the last synthesis step. In relation to the amounts of 8, the yields were good to very high, leading to 56% and 87%, respectively. The reference compound was synthesized through 19 F-fluorination of 9 using tetrabutylammonium fluoride (TBAF) at 120°C for 2 h to yield 11 in excellent yields of 82%.
The radiofluorination of precursor 9 is depicted in Scheme 2. The radiolabeling of precursors 9 and 10 was optimized using different parameters such as various bases, base concentrations, reaction times and different amounts of precursors. Initially, the use of two different bases, tetrabutylammonium hydroxide (TBA-OH) and tetraethylammonium bicarbonate (Et 4 NHCO 3 ), in acetonitrile was screened. The use of TBA-OH caused decomposition of the precursors, and a RCY of only 30% was achievable. The use of precursor 9 (7.5 mg, 12 μmol) in acetonitrile and tetraethylammonium bicarbonate gave the highest RCY of ≥90% within 10 minutes. For further evaluation of precursors 9 and 10, tetraethylammonium bicarbonate was used as base. With a base amount below 17 μmol, no 18 F-labeling was observed, while increasing the base amount to higher than 17 μmol resulted in reduced yields. Besides, the amount of precursor played an important role. Reaction kinetics were monitored for 2.5, 5.0 and 7.5 mg (4, 8 and 12 μmol) of precursor 9. By increasing the amount of precursor (12 μmol), RCYs of ≥90% after 10 min were observed. Between the two leaving groups we did not observe significant differences in RCYs. Isolation of the final 18 F-labeled prosthetic group was performed by fixation of the product fraction obtained from semi-preparative HPLC on a C18 reversed phase cartridge, followed by elution of the 18 F-prosthetic group from the resin with acetonitrile (1 mL Two different azido-functionalized α-MSH analogue peptides, N 3 -TEG-Gly-Gly-Nleu-Gly-His-DPhe-Arg-Trp-NH 2 and N 3 -TEG-Gly-Gly-Nleu-[Cys-His-DPhe-Arg-Trp-Gly-Cys]-NH 2 , with high specificities to the MC1R (melanocortin receptor 1) were prepared by using solid phase peptide synthesis (SPPS). In cases of non-quantitative 18 F-click labeling, the 18 F-labeled products were easily separated by radio-HPLC from the unreacted 18 F-prostehtic group. For the 18 F-labeled folate derivative, a low log D value of 0.6 ± 0.07 was determined. High stability was observed in human serum at 37°C over a period of 1.5 h. Further in vitro and in vivo evaluation of the new 18 F-folate using human KB cells and PET imaging is ongoing.
Similarly, investigations and evaluation using the other new 18 F-tracers derived from copper-free 18 F-click labeling in in vivo PET imaging are planned.
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